Makar, G. A., Holmes, J. H., & Yang, Y. (2014). Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. JNCI : Journal of the National Cancer Institute, 106(2), djt374. https://doi.org/10.1093/jnci/djt374
Chicago Style (17th ed.) CitationMakar, George A., John H. Holmes, and Yu-Xiao Yang. "Angiotensin-converting Enzyme Inhibitor Therapy and Colorectal Cancer Risk." JNCI : Journal of the National Cancer Institute 106, no. 2 (2014): djt374. https://doi.org/10.1093/jnci/djt374.
MLA (9th ed.) CitationMakar, George A., et al. "Angiotensin-converting Enzyme Inhibitor Therapy and Colorectal Cancer Risk." JNCI : Journal of the National Cancer Institute, vol. 106, no. 2, 2014, p. djt374, https://doi.org/10.1093/jnci/djt374.
Warning: These citations may not always be 100% accurate.